Among them, CXC ligand 12 (CXCL12, also called stromal-derived factor-1), one of CXC chemokines, was previously shown to have important impacts on proliferation and invasion of many types of cancer cells, via its specific receptor, CXCR4 [10, 11]. This evidence concerns the gene CXCR4 and cancer.